Remote Monitoring and Symptom Management Digital Application
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorPatrick C. Johnson, MD
About this trial
The goal of this clinical trial is to learn if an artificial intelligence phone application called ASSIST can help patients receiving cancer treatment.
The main question\[s\] it aims to answer are:
Is ASSIST feasible for patients (meaning can it be used by patients)? Is ASSIST acceptable to patients (meaning do patients like it)?
Researchers will compare the ASSIST phone application to see how it compares to usual clinical care.
Participants on the ASSIST arm will use the ASSIST phone application for 12 weeks, and participants in both groups will complete surveys.
Eligibility criteria
Qualifiers
Age 18 years or older
Ability to understand English
About to begin definitive systemic treatment (or within 4 weeks of beginning treatment) based upon the oncology treatment intent form for a new diagnosis of breast cancer, colorectal cancer, or lymphoma.
Expected treatment duration of at least 12 weeks
Disqualifiers
Cognitive impairment that would interfere with ability to use smartphone application (as assessed by their attending physician)
Visual or motor impairment that would prevent smartphone use
Expected survival less than 3 months
Trial design
Treatments tested in this trial
- ASSIST phone application
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Patrick C. Johnson, MD
Lead sponsor
Massachusetts General Hospital
Sponsor institution
Source ClinicalTrials.gov